Tags Life Sciences
Tag: Life Sciences
Synthetic biology startups are giving investors an appetite
There’s a growing wave of commercial activity from companies that are creating products using new biological engineering technologies.
Perhaps the most public (and tastiest) example...
Mission Bio raises $70 million to help scale its tech for improving the development of targeted cancer therapies
California-based startup Mission Bio has raised a new $70 million Series C funding round, led by Novo Growth and including participating from Soleus Capital...
Mammoth Biosciences lands exclusive license to new CRISPR proteins that could boost gene editing precision
CRISPR pioneer Mammoth Biosciences has secured an exclusive license to a new family of CRISPR proteins, from UC Berkeley, which covers R&D and commercialization...
NEA-backed Personal Genome Diagnostics receives FDA clearance for its cancer diagnostic
Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic profiling of different cancers in lab settings, has received clearance from...
Cell and gene therapy startup ElevateBio raises $170 million
While economic conditions and the ongoing global coronavirus pandemic may not make for the best atmosphere for raising funding, some companies are still announcing...
Despite Trump’s claims, Google isn’t building the coronavirus screening site — and it’s not ready
In a press conference at the White House, President Trump today announced that 1,700 Google engineers were working on a coronavirus screening site. That...
As national COVID-19 cases top 1000, insurers waive treatment fees and U.S. preps stimulus
The number of COVID-19 cases in the U.S. crossed 1,000 on Tuesday as President Donald Trump met with the nation’s largest insurers and members...
Gates, Wellcome and Mastercard launch $125 million fund to finance COVID-19 treatments
The Bill & Melinda Gates Foundation, Wellcome, and Mastercard announced a new initiative yesterday to accelerate technologies designed to identify, assess, develop, and scale...
Karius raises $165 million for its liquid biopsy technology identifying diseases in a drop of blood
“What Karius is good at is identifying those novel microbes before they become an outbreak like coronavirus,” says Mickey Kertesz, a chief executive whose...
XGenomes is bringing DNA sequencing to the masses
As healthcare moves toward genetically tailored treatments, one of the biggest hurdles to truly personalized medicine is the lack of fast, low-cost genetic testing.
And...
- Advertisment -